Bellevue Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-44,500
Closed -$4.23M 146
2018
Q3
$4.23M Hold
44,500
0.27% 78
2018
Q2
$3.44M Sell
44,500
-5,000
-10% -$375K 0.29% 67
2018
Q1
$3.42M Hold
49,500
0.34% 61
2017
Q4
$3.69M Hold
49,500
0.39% 56
2017
Q3
$3.13M Hold
49,500
0.33% 65
2017
Q2
$3.16M Hold
49,500
0.37% 63
2017
Q1
$3.26M Hold
49,500
0.43% 62
2016
Q4
$3.4M Hold
49,500
0.7% 41
2016
Q3
$3.49M Sell
49,500
-15,500
-24% -$1.16M 0.63% 50
2016
Q2
$4.93M Buy
65,000
+6,400
+11% +$471K 0.93% 39
2016
Q1
$4.03M Buy
+58,600
New +$4.21M 0.73% 47

Other funds holding ESRX

Bellevue Group's ESRX Position: Q4 2018 in Review

Bellevue Group sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 44,500 shares — an estimated $4.23M sold.

Bellevue Group first reported a position in ESRX in Q1 2016 and held it in 11 quarters. The position peaked at $4.93M in Q2 2016. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Bellevue Group reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Bellevue Group sold 44,500 Express Scripts Holding Company shares in Q4 2018, an estimated $4.23M.
  • Bellevue Group first reported a position in Express Scripts Holding Company in Q1 2016 and held it in 11 quarters.
  • Bellevue Group's Express Scripts Holding Company position peaked at $4.93M in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Bellevue Group's 13F filing for Q4 2018, filed 12 Feb 2019.